Are alterations of lymphocyte subpopulations in polymicrobial sepsis and DHEA treatment mediated by the tumour necrosis factor (TNF)-α receptor (TNF-RI)? A study in TNF-RI (TNF-RI-/-) knock-out rodents

Clinical and Experimental Immunology

Volumn 138, Issue 2, 2004, Pages 221-229

  Hildebrand, F ^a   Pape, H C ^a   Harwood, P ^b   Wittwer, T ^a   Krettek, C ^a   Van Griensven, Martijn ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Dehydroepiandrosterone (DHEA); Lymphocytes; Mortality sepsis tumour necrosis factor receptor I (TNF RI)

Indexed keywords

PRASTERONE; SEX HORMONE; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CELLULAR IMMUNITY; CONTROLLED STUDY; IMMUNE RESPONSE; KNOCKOUT MOUSE; LYMPHOCYTE SUBPOPULATION; MALE; MORTALITY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SEPSIS; T LYMPHOCYTE;

ANIMALS; BODY TEMPERATURE; BODY WEIGHT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DEHYDROEPIANDROSTERONE; HYPERSENSITIVITY, DELAYED; IMMUNITY, CELLULAR; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LYMPHOCYTE COUNT; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SEPSIS; T-LYMPHOCYTE SUBSETS;

EID: 8144229132     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2004.02598.x     Document Type: Article

References (47)

1. Levy EM, Alharbi SA, Grindlinger G, Black PH. Changes in mitogen responsivness of lymphocyte subsets after traumatic injury: relation to development of sepsis. Clin Immunol Immunopathol 1984; 32:224-8.
2. Pape HC, Remmers D, Grotz M, Tscherne H. Reticuloendothelial system activity and organ failure in multiply injured patients. Arch Surg 1999; 134:421-7.
3. Gadd MA, Hansbrough JF, Hoyt DB, Ozkan AN. Defective T cell surface antigen expression after mitogen stimulation. An index of lymphocyte dysfuction after controlled murine injury. Ann Surg 1989; 209:112-9.
4. Hoyt DB, Ozkan AN, Hansbrough JF, Marshall L, van Berkum-Clark M. Head injury: an immunologic deficit in T cell activation. J Trauma 1990; 30:759-65.
5. Blackwell TS, Christman JW. Sepsis and cytokines: current status. Br J Anaesth 1996; 77:110-5.
6. Grell M, Becke FM, Wajant H, Mannel DN, Scheurich P. TNF receptor type 2 mediates thymocyte proliferation independently of TNF receptor type 1. Eur J Immunol 1998; 28:257-63.
7. Joseph SB, Miner KT, Croft M. Augmentation of naive, Th1 and Th2 effector CD4 responses by IL-6, IL-1 and TNF. Eur Immunol 1998; 28:277-89.
8. Zellweger R, Wichmann MW, Ayala A, Stein S, Demaso CM, Chaudry IH. Females in proestrus state maintain splenic immune functions and tolerate sepsis better than males. Crit Care Med 1997; 25:106-10.
9. Kahlke V, Angele MK, Ayala A et al. Immune dysfunction following trauma-haemorrhage: influence of gender and age. Cytokine 2000; 12:69-77.
10. Straub RH, Lehle K, Herfarth H et al. Dehydroepiandrosterone in relation to other adrenal hormones during an acute inflammatory stressful disease state compared with chronic inflammatory disease: role of interleukin-6 and tumor necrosis factor. Eur J Endocrinol 2002; 146:365-74.
11. Okabe T, Haji M, Takayanagi R et al. Up-regulation of high-affinty dehydroepiandrosterone binding activity by dehydroepiandrosterone in activated human T-lymphocytes. J Clin Endocrinol Metab 1995; 80:2993-8.
12. Beishuizen A, Thijs LG, Vermes I. Decreased levels of dehydroepiandrosterone sulphate in severe critical illness: a sign of exhausted adrenal reserve. Crit Care Med 2002; 6:434-8.
13. Marx C, Petros S, Bornstein SR et al. Adrenocortical hormones in survivors and nonsurvivors of severe sepsis: diverse time course of dehydroepiandrosterone, dehydroepiandrpsterone-sulphate, and cortisol. Crit Care Med 2003; 31:1382-8.
14. Catania RA, Angele MK, Ayala A, Ciuffi WG, Bland KI, Chaudry IH. Dehydroepiandrosterone restores immune function following traumahaemorrhage by a direct effect on T-lymphocytes. Cytokine 1999; 11:443-50.
15. Danenberg HD, Alpert G, Lustig S, Ben-Nathan D. Dehydroepiandrosterone protects mice from endotoxin toxicity and reduces tumor necrosis factor production. Antimicrob Agents Chemother 1992; 36:2275-9.
16. Casson PR, Andersen RN, Herrod HG et al. Oral dehydroepiandrosterone in physiologic doses modulates imune function in postmenopausal women. Am J Obstet Gynecol 1993; 169:1536-9.
17. van Griensven M, Dahlweid M, Giannoudis PV et al. Dehydroepiandrosterone (DHEA) modulates the activity and the expression of lymphocyte subpopulations induced by cecal ligation and puncture. Shock 2002; 18:445-51.
18. Leon LR, White AA, Kluger MJ. Role of IL-6 and TNF in thermoregulation and survival during sepsis in mice. Am J Physiol 1998; 275:R269-77.
19. Di Santo E, Foddi MC, Ricciardi-Castagnoli P, Mennini T, Ghezzi P. DHEAS inhibits TNF production in monocytes, astrocytes and microglial cells. Neuroimmunomodulation 1996; 3:285-8.
20. Bazzoni F, Beutler B. The tumor necrosis factor ligand and receptor families. N Engl J Med 1996; 334:1717-25.
21. Pfeffer K. Biological functions of tumor necrosis factor cytokines and their receptors. Cytokine Growth Factor Rev 2003; 14:185-91.
22. Echtenacher B, Falk W, Mannel DN, Krammer PH. Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. J Immunol 1990; 145:3762-6.
23. Sheppard BC, Fraker DL, Norton JA. Prevention and treatment of endotoxin and sepsis lethality with recombinant human tumor necrosis factor. Surgery 1989; 106:156-61.
24. Calandra T, Baumgartner JD, Grau GE, Wu MM, Lambert PH, Schellekens J. Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-α, and interferon-gamma in the serum of patiens with septic shock. J Infect Dis 1990; 161:928-37.
25. Acton RD, Dahlberg PS, Uknis ME et al. Differential sensitivity to Escherichia coli infection in mice lacking tumor necrosis factor p55 or interleukin-1 p80 receptors. Arch Surg 1996; 131:1216-21.
26. O'Brien DP, Briles DE, Szalai AJ, Tu AH, Sanz I, Nahm MH. Tumor necrosis factor alpha receptor I is important for survival from Streptococcus pneumoniae infections. Infect Immun 1999; 67:595-601.
27. Abraham E, Anzueto A, Gutierrez G et al. Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group. Lancet 1998; 351:929-33.
28. Fisher CJ JR, Agosti JM, Opal SM et al. Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N Engl J Med 1996; 334:1697-702.
29. Ayala A, Deol ZK, Lehmann DL, Herdon CD, Chaudry IH. Polymicrobial sepsis but not low-dose endotoxin infusion causes decreased splenocyte IL-2/IFN-gamma release while increasing IL-4/IL-10 production. J Surg Res 1994; 56:579-85.
30. Dhabhar FS, McEwen BS. Acute stress enhances while chronic stress suppresses cell-mediated immunity in vivo: a potential role for leukocyte trafficking. Brain Behav Immun 1997; 11:286-306.
31. Oberbeck JR, Dahlweid FM, Koch R et al. Dehydroepiandrosterone decreases mortality rate and improves cellular immune function during polymicrobial sepsis. Crit Care Med 2001; 29:380-4.
32. Araneo BA, Shelby J, Li GZ, Ku W, Daynes RA. Administration of dehydroepiandrosterone to burned mice preserves normal immunologic competence. Arch Surg 1993; 128:318-25.
33. Rook GA, Hernandez-Pando R, Lightman SL. Hormones, peripherally activated prohormones and regulation of the Th1/Th2 balance. Immunol Today 1994; 15:301-3.
34. Meikle AW, Dorchuck RW, Araneo BA et al. The presence of a dehydroepiandrosterone-specific receptor binding complex in murine T cells. J Steroid Biochem Molec Biol 1992; 42:293-304.
35. Daynes RA, Araneo BA, Dowell TA, Huang K, Dudley D. Regulation of murine lymphokine production in vivo. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function. J Exp Med 1990; 171:979-96.
36. Blauer KL, Poth M, Rogers WM, Bernton EW. Dehydroepiandrosterone antagonizes the suppressive effects of dexamethasone on lymphocyte proliferation. Endocrinology 1991; 129:3174-9.
37. Kondo S, Wang B, Fujisawa H et al. Effect of gene-targeted mutation in TNF receptor (p55) on contact hypersensitivity and ultraviolet B-induced immunosuppression. J Immunol 1995; 155:3801-5.
38. Artis D, Humphreys NE, Bancroft AJ, Rothwell NJ, Potten CS, Grencis RK. Tumor necrosis factor alpha is a critical component of interleukin 13-mediated protective T helper cell type 2 responses during helminth infection. J Exp Med 1999; 190:953-62.
39. Christou NV. Host-defence mechanisms in surgical patients, a correlative study of the delayed hypersensitivity skin-test response, granulocyte function and sepsis. Can J Surg 1985; 28:39-46.
40. Casson PR, Andersen RN, Herrod HG et al. Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal women. Am J Obstet Gynecol 1993; 169:1536-9.
41. + T lymphocytes during polymicrobial sepsis is mediated by Fas ligand and not endotoxin. Immunology 1999; 97:45-55.
42. Ksontini R, Colagiovanni DB, Josephs MD et al. Disparate roles for TNF-alpha and Fas ligand in concanavalin A-induced hepatitis. J Immunol 1998; 160:4082-9.
43. Oberbeck R, Nickel E, van Griensven M et al. The effect of dehydroepiandrosterone on hemorrhage-induced suppression of cellular immune function. Intensive Care Med 2002; 28:963-8.
44. Carson WE, Yu H, Dierksheide J et al. A fatal cytokine-induced systemic inflammatory response reveals a critical role for NK cells. J Immunol 1999; 162:4943-51.
45. Unanue ER. Macrophages, NK cells and neutrophils in the cytokine loop of Listeria resistance. Res Immunol 1996; 147:499-505.
46. van Vollenhoven RF, Engleman EG, McGuire JL. Dehydroepiandrosterone in systemic lupus erythematosus: results of a double blind, placebo-controlled, randomized clinical trial. Arthritis Rheum 1995; 38:1826-31.
47. Knöferl MW, Angele MK, Catania RA, Diodato MD, Bland KI, Chaudry IH. Immunomodulatory effects of dehydroepiandrosterone in prostrus female mice after trauma-hemorrhage. J Appl Physiol 2003; 95:529-35.